SCHEMBL9959332

SCHEMBL9959332

COc1cc(NC(=O)C(=O)c2c(C)n(Cc3ncc(Cl)cc3F)c3cc(F)c(OC)cc23)ccn1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.61
P2RX3 P56373 2/20 0.35
SCN10A Q9Y5Y9 1/20 0.34
GRM4 Q14833 1/20 0.34
AXL P30530 2/20 0.33
AURKA O14965 2/20 0.33
AURKB Q96GD4 2/20 0.33
DDR1 Q08345 1/20 0.33
MET P08581 5/20 0.33
ENPP1 P22413 1/20 0.33
MAPK1 P28482 1/20 0.33
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
ROCK1 Q13464 1/20 0.32
CNR1 P21554 1/20 0.32
KDR P35968 2/20 0.32
JAK2 O60674 1/20 0.32
RPS6KA5 O75582 1/20 0.32
ABL1 P00519 1/20 0.32
INSR P06213 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9953581 0.95 FAAH (0.60) FAAHP2RX3SCN10AGRM4AXL
SCHEMBL9958930 0.95 FAAH (0.60) FAAHP2RX3SCN10AGRM4MAPK1
SCHEMBL9958878 0.92 FAAH (0.57) FAAHP2RX3SCN10AAXLAURKA
SCHEMBL9958843 0.91 FAAH (0.75) FAAHP2RX3SCN10AMAPK1CYP3A4
SCHEMBL9953355 0.89 FAAH (0.66) FAAHMAPK1CYP3A4
SCHEMBL9952749 0.89 FAAH (0.64) FAAHP2RX3SCN10AGRM4AXL
SCHEMBL9959333 0.89 FAAH (0.77) FAAHP2RX3AXLAURKAAURKB
SCHEMBL9958687 0.88 FAAH (0.64) FAAHP2RX3SCN10AGRM4AXL
SCHEMBL9958868 0.88 FAAH (0.63) FAAHSCN10ACNR1MAPK3
SCHEMBL9952414 0.86 FAAH (0.64) FAAHP2RX3SCN10AMETCNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9657012-B2 FAAH inhibitors IRONWOOD PHARMACEUTICALS, INC. (US) 2017-05-23 US disclosed
US-9657012-B2 FAAH inhibitors IRONWOOD PHARMACEUTICALS, INC. (US) 2017-05-23 US disclosed
US-9657012-B2 FAAH inhibitors IRONWOOD PHARMACEUTICALS, INC. (US) 2017-05-23 US disclosed
EP-2655356-B1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS INC (US) 2016-08-03 EP disclosed
EP-2655356-B1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS INC (US) 2016-08-03 EP disclosed
US-20150175599-A1 FAAH Inhibitors IRONWOOD PHARMACEUTICALS, INC. (US) 2015-06-25 US disclosed
WO-2014004676-A1 USE OF FAAH INHIBITORS AS NEUROPROTECTIVE AGENTS IN THE CNS IRONWOOD PHARMACEUTICALS, INC. (US) 2014-01-03 WO disclosed
EP-2655356-A1 FAAH INHIBITORS Ironwood Pharmaceuticals, Inc. (US) 2013-10-30 EP disclosed
WO-2012088469-A1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS, INC. (US) 2012-06-28 WO disclosed
WO-2012088469-A1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS, INC. (US) 2012-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150175599-A1 FAAH Inhibitors FAAH, FAAH2, ASAH1 FAAH 1/4885P2RX3 508/4885SCN10A 1371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.